Skip to main content

Part of the book series: Yearbook of Intensive Care and Emergency Medicine ((YEARBOOK,volume 2006))

  • 660 Accesses

Conclusion

Hyaluronan in HMW forms serves as an organizer of the extracellular matrix of the lung, but LMW forms act as signaling molecules that are involved in the production of inflammatory cytokines. LMW hyaluronan is produced either by breakdown of HMW hyaluronan or by de novo synthesis by HAS3. LMW hyaluronan regulates cytokine production through binding to cell surface receptors, CD44, RHAMM and TLRs. We have shown that in VILI, a form of ALI, LMW hyaluronan is produced through upregulation of HAS3 and plays an important role in production of chemokines and neutrophil infiltration found in VILI. LMW hyaluronan-induced IL-8 production in lung cells is dependent on NF-κB and JNK/AP-1 activation. Our clinical studies of LMW hyaluronan in patients at risk of ALI and patients with ALI/ARDS suggest that LMW hyaluronan may play an important role in the pathogenesis of ALI/ARDS and may offer targets for new treatment modalities.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Starcher B (2000) Lung elastin and matrix. Chest 117:229S–234S

    Article  CAS  PubMed  Google Scholar 

  2. Hance AJ and Crystal RG (1975) The connective tissue of lung. Am Rev Respir Dis 112:657–709

    CAS  PubMed  Google Scholar 

  3. Nobel PW (2002) Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21:25–29

    Article  Google Scholar 

  4. Savani RC, DeLisser HM (2002) Hyaluronan and its receptors in lung health and disease. In: Garg HG, Roughley PJ, Hales CA (eds) Proteoglycans in Lung Disease. Marcel Dekker, New York, pp 23–36

    Google Scholar 

  5. McKee CM, Penno MG, Cowan M, et al (1996) Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 98:2403–2413

    Article  CAS  PubMed  Google Scholar 

  6. Horton MR, McKee CM, Bao C, et al (1998) HA fragments synergize with interferon-gamma to induce C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem 273:35088–35094

    Article  CAS  PubMed  Google Scholar 

  7. Noble PW, McKee CM, Cowman M, Shin HS (1996) Hyaluronan fragments activate an NF-κB/IκBa autoregulatory loop in murine macrophages. J Exp Med 183:2373–2378

    Article  CAS  PubMed  Google Scholar 

  8. Sztrolovics R, Recklies AD, Roughley PJ, Mort JS (2002) Hyaluronate degradation as an alternative mechanism for proteoglycan release from cartilage during interleukin-1β-stimulated catabolism. Biochem J 362:473–479

    Article  CAS  PubMed  Google Scholar 

  9. Itano N, Sawani T, Lenas P, et al (1999) Three isoforms of mammalian HA synthase have distinct enzymatic properties. J Biol Chem 274:25085–25092

    Article  CAS  PubMed  Google Scholar 

  10. Spicer AP, Augustine MI, McDonald JA (1996) Molecular cloning and characterization of a putative mouse hyaluronan synthase. J Biol Chem 271:23400–23406

    Article  CAS  PubMed  Google Scholar 

  11. Camenisch TD, Spicer AP, Brehm-Gibson T, et al (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 206:349–360

    Article  Google Scholar 

  12. Turley EA, Noble PW, Bourguignon L (2002) Signaling properties of hyaluronan receptors. J Biol Chem 277:4589–4592

    Article  CAS  PubMed  Google Scholar 

  13. Teder P, Vandivier RW, Jiang D, et al (2002) Resolution of lung inflammation by CD44. Science 296:155–158

    Article  CAS  PubMed  Google Scholar 

  14. Termeer C, Benedix F, Sleeman J, et al (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195:99–111

    Article  CAS  PubMed  Google Scholar 

  15. Taylor KR, Trowbridge JM, Rudisill JA, et al (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279:17079–17084

    Article  CAS  PubMed  Google Scholar 

  16. Tremblay L, Valenza F, Ribeiro S, Li J, Slutsky A (1997) Injurious ventilatory strategies increase cytokines and c-fos mRNA expression in an isolated rat lung model. J Clin Invest 99:944–952

    Article  CAS  PubMed  Google Scholar 

  17. Quinn DA, Moufarrej RK, Volokhov A, Hales CA (2002) Interactions of lung stretch, hyperoxia, and MIP-2 production in ventilator-induced lung injury. J Appl Physiol 93:517–525

    CAS  PubMed  Google Scholar 

  18. Mascarenhas MM, Day RM, Ochoa CD, et al (2004) Low molecular weight hyaluronan from stretched lung enhances IL-8 expression. Am J Respir Cell Mol Biol 30:51–60

    Article  CAS  PubMed  Google Scholar 

  19. Li LF, Yu L, Quinn DA (2004) Ventilation-induced neutrophil infiltration depends on c-jun n-terminal kinase. Am J Respir Crit Care Med 169:518–524

    Article  PubMed  Google Scholar 

  20. Bai KJ, Spicer AP, Mascarenhas MM, et al (2005) The role of hyaluronan synthase 3 in ventilator-induced lung injury. Am J Respir Crit Care Med 172:92–98

    Article  PubMed  Google Scholar 

  21. Bennett BL, Sasaki DT, Murray BW, et al (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98:13681–13686

    Article  CAS  PubMed  Google Scholar 

  22. Bergstrom CE, Eklund A, Skold M, Tornling G (1997) Bronchoalveolar lavage findings in firefighters. Am J Ind Med 32:332–336

    Article  CAS  PubMed  Google Scholar 

  23. Sahu S (1980) Hyaluronic acid: an indicator of pathological conditions of human lungs. Inflammation 4:107–112

    Article  CAS  PubMed  Google Scholar 

  24. Sahu S, Lynn WS (1978) Hyaluronic acid in pulmonary secretion of patients with asthma. Biochem J 173:565–568

    CAS  PubMed  Google Scholar 

  25. Sahu S, Lynn WS (1978) Hyaluronic acid in pulmonary secretion of patients with alveolar proteinosis. Inflammation 3:149–158

    Article  CAS  PubMed  Google Scholar 

  26. Hallgren R, Eklund A, Engstrom-Laurent A, Aechmekel B (1985) Hyaluronate in bronchoalveolar lavage fluid, a new marker in sarcoidosis reflecting pulmonary disease. BMJ 290:1778–1781

    Article  CAS  PubMed  Google Scholar 

  27. Bjermer L, Engstrom-Laurent A, Laundger R, Rosenhall L, Hallgren R (1987) Hyaluronate and type III procollagen peptide concentration in BAL as marker of disease activity in farmer’s lung. BMJ 295:803

    Article  CAS  PubMed  Google Scholar 

  28. Bjermer L, Lundgren R, Hallgren R (1989) Hyaluronan in type III collagen peptide concentration in BAL in idiopathic pulmonary fibrosis. Thorax 44:126–131

    Article  CAS  PubMed  Google Scholar 

  29. Sato H, Onose J, Toyoda H, et al (2001) Quantitative changes in glycosaminoglycans in the lungs of rats exposed to diesel exhaust. Toxicol 166:119–128

    Article  CAS  Google Scholar 

  30. Hallgren R, Samelson T, Laurent TC, Modig J (1989) Accumulation of hyaluronan (hyaluronic acid) in lung in ARDS. Am Rev Respir Dis 139:682–687

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Quinn, D.A., Garg, H.G. (2006). Hyaluronan in Acute Lung Injury. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine. Yearbook of Intensive Care and Emergency Medicine, vol 2006. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-33396-7_32

Download citation

  • DOI: https://doi.org/10.1007/3-540-33396-7_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-30155-4

  • Online ISBN: 978-3-540-33396-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics